- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02003404
Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin
October 5, 2016 updated by: Hollister Incorporated
This purpose of this study is to look at three commercially available ostomy barriers on peristomal (around the stoma) skin.
Repeated barrier application and removal over years causes changes to the skin that the investigators wish to investigate.
The primary objective is to measure peel force on normal skin and peel force on peristomal skin, with the intent of determining if differences occur.
The study hypotheses is that no differences exist.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single center, non-invasive exploratory study utilizing a sample of convenience.
This study compares three commercially available barrier materials on peristomal skin and normal abdominal skin.
Study Type
Observational
Enrollment (Actual)
17
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
La Grange Park, Illinois, United States, 60526
- La Grange Center for Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Ostomates with a normal peristomal skin and normal ipsilateral abdominal skin
Description
Inclusion Criteria:
- Colostomy, Ileostomy, or Urostomy patients at least 6 months post-surgery
- Males or females, age 18 to 80 years old at the time of enrollment
- Body Mass Index (BMI) between 18 and 50
- Willing to have two approximately 5" x 5" areas of the abdomen trimmed with a surgical clipper -- one in a ring around the stoma, and one on the opposite side
- Willing to remain within the testing room for the duration of the study
- Willing to allow a third person in the room as a witness for the duration of the study
- Able to position oneself onto and off of the examining table without the assistance of the Investigator
- Willing to refrain from vigorous exercise for the duration of the study
- Willing to not take any anti-inflammatory medications (except for Tylenol/acetaminophen) starting 48 hours prior to the study and for the duration of the study
- Willing to bring an extra barrier and replace their barrier worn during the study.
- Willing to follow the protocol as demonstrated by signing the Informed Consent Form
- In the opinion of the Investigator or qualified site personnel is qualified to participate
Exclusion Criteria:
- Clinically significant diseases, which may or may not be confined to the testing site, that may contraindicate participation; including but not limited to psoriasis, eczema, atopic dermatitis, and active cancer
- Use of topical drugs on the application site within 1 month.
- Use of lotions, creams, powders or oils on the application site in the 24 hours prior to application
- Pregnancy, lactation or planning a pregnancy as determined by interview only
- Other medical conditions, for example uncontrolled diabetes, which in the Investigator's judgment, makes the subject ineligible or places the subject at undue risk
- Participation in any clinical test either using the abdomen as a test site or using systemic therapy within the previous thirty days
- Damaged skin or other skin conditions in or near test sites which includes sunburn, scars, numerous moles or other disfiguration of the test site
- Significant adipose tissue at the test site that would preclude adequate adhesion of the study devices
- Known allergy to any of the test materials
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control Abdominal Skin
Apply SoftFlex (standard wear commercial skin barrier), FlexWear (standard wear commercial skin barrier), and FlexTend (extended wear commercial skin barrier), material to non-peristomal abdominal skin.
|
Three barrier materials will be peeled from abdominal skin after a set period at a set rate.
Other Names:
|
Peristomal Abdominal Skin
Apply SoftFlex, FlexWear and FlexTend barrier material to peristomal abdominal skin.
|
Three barrier materials will be peeled from abdominal skin after a set period at a set rate.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin Barrier Peel Force
Time Frame: 4 hours
|
Peel force of barrier materials, comparing peristomal skin to abdominal skin.
A portable peel force analyser, previously validated, was used in the clinic to measure peel at 90 degrees to the plane of the body.
Peel force was measured on peristomal skin and ipsilateral abdominal skin in the same subject.
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: James Swan, MD, Loyola University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
November 20, 2013
First Submitted That Met QC Criteria
December 5, 2013
First Posted (Estimate)
December 6, 2013
Study Record Updates
Last Update Posted (Estimate)
November 11, 2016
Last Update Submitted That Met QC Criteria
October 5, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5642-O
- LUHSC IRB #: 205654091813 (Other Identifier: Hollister Incorporated)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermatologic Complications
-
Mayo ClinicActive, not recruitingPain | Malignant Neoplasm | Dermatologic ComplicationsUnited States
-
Northwestern UniversityCompletedDermatologic DisordersUnited States
-
DermTechRecruitingDermatologic DiseasesUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
University of California, IrvineBeckman Laser Institute University of California IrvineRecruitingDermatologic DiseasesUnited States
-
Pusan National University HospitalCompletedDermatologic Disorders | Injury Due to LaserKorea, Republic of
-
Sohag UniversityNot yet recruitingDermatologic Disorders With Heamatologic Malignancies PatientsEgypt
-
National Institute of Arthritis and Musculoskeletal...RecruitingDermatologic Diseases | Systemic Diseases With Cutaneous ManifestationsUnited States
Clinical Trials on Control Abdominal Skin
-
South Valley UniversityCompletedCommon Bile Duct Injury
-
3MCompletedBacterial Recovery of Skin Flora Post-Product ApplicationUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompletedMorality | Skin Graft ComplicationsChina
-
Molde University CollegeNorwegian University of Science and TechnologyCompletedHealthy
-
Saglik Bilimleri UniversitesiCompletedSkin to Skin ContactTurkey
-
Pusan National University Yangsan HospitalCompleted
-
Purdue UniversityUSDA Beltsville Human Nutrition Research CenterCompletedAppetitive Behavior | Glycemic ResponseUnited States
-
University of Colorado, Colorado SpringsRecruitingBlood Pressure | Blood LossUnited States
-
Aydin Adnan Menderes UniversityCompletedPrimary DysmenorrheaTurkey
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, Caen; University Hospital, Lille and other collaboratorsRecruitingPreterm Infant | Body TemperatureFrance